Brandon May

Investigators discuss an added benefit of using DPP4 inhibitors would be a lower incidence of hypoglycemia.

Investigators believe that circulating adipokines may be associated with the development of preeclampsia in women with type 1 diabetes in the first trimester.

Exposure to diabetogenic environmental endocrine-disrupting chemicals (EDCs) is higher among Latinos, African Americans, and low-income populations.

Investigators assess maternal hyperglycemia exposure to fetus with neonatal health outcomes.

Investigators assessed the utilization of ATA risk stratification and TI-RADS ultrasound based systems for the assessment of pediatric thyroid nodules.

Despite the well‐recognized correlation between weight gain and cardiovascular (CV) disease, there is little direct evidence relating to the impact of insulin‐induced weight gain on CV outcomes.

Long-term exposure to progestin-only oral contraceptives or to a progestin intrauterine device is associated with a small beneficial effect on pelvic girdle pain.

Dapagliflozin improves glycemic control in patients with inadequately controlled type 1 diabetes currently taking insulin.

A new study suggests that pancreatic exocrine dysfunction develops after initiation of islet cell autoimmunity, suggesting that exocrine dysfunction is related to diabetes disease pathogenesis itself.

There is a need for bridging the disconnect between policies that address underweight and overweight children and adolescents.

Levels of high sensitivity C-reactive protein may help risk stratify those patients with T2D and recent acute coronary syndrome at further risk of recurrent cardiovascular events.

Higher-dose and specialized treatment content designed to help families maintain weight-control behaviors following family-based behavioral weight loss treatment enhances weight outcomes.

Grip strength has clinical utility in identifying people with diabetes at risk for poor health outcomes.

The association between statin use and diabetes risk in a cohort of overweight and obese patients was examined.

Researchers assessed whether long-term use of long-acting insulin analogs, compared with the use of neutral protamine Hagedorn insulin, is associated with an increased risk of breast cancer in women with T2D.

Investigators encourage further research on the use of NSAIDs in women with preeclampsia who develop postpartum hypertension.

Acarbose, an α-glucosidase inhibitor, decreased the incidence of diabetes in a population with impaired glucose tolerance who were at low risk of cardiovascular events.

A study confirms whether severe hypoglycemia increases risk for all-cause mortality in patients with type 2 diabetes.

A retrospective analysis examined outcomes in patients with type 2 diabetes treated with SGLT2 vs DPP4 inhibitors.